Asia Pacific faces hepatitis crisis: Urgent action needed to meet WHO targets

FHS
July 1, 2024
11:54 am

Countries in Asia Pacific are unlikely to meet their commitment to eliminate hepatitis by 2030 unless they declare a public health emergency, as they did with COVID-19, a disease specialist suggested.

Cabozantinib Plus Atezolizumab Improves PFS in Metastatic CRPC

In patients with metastatic castration-resistant prostate cancer (mCRPC) whose disease progressed on a novel hormonal therapy, the combination of cabozantinib (Cabometyx) plus atezolizumab (Tecentriq) improved

February 23, 2024

More Evidence Favors a Shorter Course of Post-Mastectomy RT

Hypofractionated post-mastectomy radiation therapy (RT) with breast reconstruction proved noninferior to standard RT when it came to reconstruction complications, high-grade toxicity, and local control, according

October 2, 2024

TLDR – TDR News – March 4th to March 5th

Get a quick update on today’s essential news! We’ve condensed the most important information about Cannabis, Psychedelics, Crypto, AI and Largest Dollar Volume Mega Caps

March 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.